NVO Novo Nordisk A/S
company
SEC Filings & Insider Trading Activity 2026

CIK: 353278
Health Care
Pharmaceutical Preparations 48 filings
6-K: 33
20-F: 11
SC 13G: 4

Go deeper on Novo Nordisk A/S

Ask AI about NVO filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.

Track institutional money. See which funds are building or cutting NVO positions, quarter over quarter.

Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on NVO.

See Pro plans →

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling DatePeriodAnalysisSEC
6-K
Aug 4, 2026---
6-K
Aug 4, 2026---
6-K
Aug 4, 2026---
6-K
Jul 31, 2026---
6-K
Jul 27, 2026---
6-K
Jul 21, 2026---
6-K
Jul 13, 2026---
6-K
Jul 6, 2026---
6-K
Jun 29, 2026---
6-K
Jun 24, 2026---
6-K
Jun 15, 2026---
6-K
Jun 8, 2026--
6-K
Jun 1, 2026--
6-K
May 27, 2026--
6-K
May 18, 2026--
6-K
May 13, 2026--
6-K
May 6, 2026--
6-K
May 5, 2026---
6-K
Apr 27, 2026---
6-K
Apr 20, 2026---
6-K
Apr 20, 2026---
6-K
Apr 13, 2026---
6-K
Apr 7, 2026---
6-K
Mar 30, 2026---
6-K
Mar 27, 2026---

13F Fund Holdings: Quarterly Trend

Latest: Q1 2026

Aggregate NVO share value held by 13F filers tracked by SignalX, by quarter.

Position changes: Q4 2025 → Q1 2026
Top Buyers
Top Sellers
New Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 307 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.

Related Health Care Companies

Browse all Health Care companies →

Frequently Asked Questions

Where can I find NVO insider trading activity (Form 4)?

SignalX aggregates every NVO Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does NVO file with the SEC?

Novo Nordisk A/S (NVO) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new NVO filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Novo Nordisk A/S (NVO).

What is NVO's SEC CIK number?

Novo Nordisk A/S (NVO)'s SEC CIK (Central Index Key) number is 353278. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 353278 to look up all NVO filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Stay on top of Novo Nordisk A/S SEC filings

Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 48+ filings.